Table 4.
Thiols (µmol/g) | |||||
Thiols (µmol/g) | — | ||||
IMA/ALB (g/L) | |||||
IMA/ALB (g/L) | 0.074 | — | |||
Fluo-AGE (AU) | |||||
Fluo-AGE (AU) | 0.068 | 0.011 | — | ||
AGE (ng/mL) | |||||
AGE (ng/mL) | 0.072 | 0.027 | 0.036 | — | |
GA (mg/L) | |||||
GA (mg/L) | 0.061 | 0.174 | 0.103 | 0.4312∗∗∗ | — |
Fructosamines (mol/g) | 0.151 | 0.181 | 0.012 | 0.110 | 0.230 |
Glycation parameters: fructosamine, glycated albumin (GA); oxidation parameters: ischemia-modified albumin (IMA), thiols; glycoxidation parameters: advanced glycation end-products (AGE), fluorescent advanced glycation end-products (Fluo-AGE). The panel includes diabetic patients with and without vascular disease (N = 75). Univariate correlation coefficients and significance between different biochemical parameter values compared by peer were calculated according to Pearson's method: ∗∗∗p < 0.001.